Alk Abello Drug Patent Portfolio
Alk Abello owns 1 orange book drug protected by 8 US patents Given below is the list of Alk Abello's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11246863 | Ciprofloxacin otic composition and kits and method for using same | 27 Nov, 2038 | Active |
| US11040004 | Otic gel formulations for treating otitis externa | 12 Nov, 2037 | Active |
| US9220796 | Sterilization of ciprofloxacin composition | 01 Jul, 2035 | Active |
| US8318817 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | 27 Apr, 2030 | Active |
| US9233068 | Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders | 11 Dec, 2029 | Active |
| US11369566 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | 21 Apr, 2029 | Active |
| US9205048 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | 21 Apr, 2029 | Active |
| US9603796 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders | 21 Apr, 2029 | Active |
Latest Legal Activities on Alk Abello's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Alk Abello.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 05 Feb, 2024 | US9220796 |
|
Expire Patent
Critical
| 15 Jan, 2024 | US9205048 |
|
Maintenance Fee Reminder Mailed
Critical
| 21 Aug, 2023 | US9220796 |
|
Maintenance Fee Reminder Mailed
Critical
| 31 Jul, 2023 | US9205048 |
|
Recordation of Patent Grant Mailed
Critical
| 28 Jun, 2022 | US11369566 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 28 Jun, 2022 | US11369566 |
|
Email Notification
Critical
| 09 Jun, 2022 | US11369566 |
|
Issue Notification Mailed
Critical
| 08 Jun, 2022 | US11369566 |
|
Application Is Considered Ready for Issue
Critical
| 31 May, 2022 | US11369566 |
| Dispatch to FDC | 31 May, 2022 | US11369566 |
|
Email Notification
Critical
| 31 May, 2022 | US11369566 |
|
Mail Response to 312 Amendment (PTO-271)
Critical
| 31 May, 2022 | US11369566 |
|
Response to Amendment under Rule 312
Critical
| 25 May, 2022 | US11369566 |
|
Pubs Case Remand to TC
Critical
| 19 May, 2022 | US11369566 |
| Supplemental Papers - Oath or Declaration | 18 May, 2022 | US11369566 |
Alk Abello's Family Patents
Alk Abello drugs have patent protection in a total of 20 countries. It has a significant patent presence in the US with 50.5% of its patents being US patents. 3 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Alk Abello Drug List
Given below is the complete list of Alk Abello's drugs and the patents protecting them.
1. Otiprio
Otiprio is protected by 8 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11246863 | Ciprofloxacin otic composition and kits and method for using same |
27 Nov, 2038
(13 years from now)
| Active |
| US11040004 | Otic gel formulations for treating otitis externa |
12 Nov, 2037
(12 years from now)
| Active |
| US9220796 | Sterilization of ciprofloxacin composition |
01 Jul, 2035
(10 years from now)
| Active |
| US8318817 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
27 Apr, 2030
(4 years from now)
| Active |
| US9233068 | Controlled release antimicrobial compositions and methods for the treatment of OTIC disorders |
11 Dec, 2029
(4 years from now)
| Active |
| US11369566 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
21 Apr, 2029
(3 years from now)
| Active |
| US9205048 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
21 Apr, 2029
(3 years from now)
| Active |
| US9603796 | Controlled release antimicrobial compositions and methods for the treatment of otic disorders |
21 Apr, 2029
(3 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Otiprio's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List